Specifica, a Q² Solutions company, is applying its proven platform for antibody discovery to generate recombinant monoclonal antibody reagents. Our in vitro display approach eliminates the need for immunization, addressing animal welfare concerns and insufficient quantities of antigen. Delivery of recombinant sequences ensures higher specificity and reproducibility than animal-based methods, as well as the ability to easily engineer these reagents. Our services include:

• Tool reagents to validate your discovery research
• Anti-idiotypes (anti-ids) for drug discovery